Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin

Hiroshima University

Status: Completed

Conditions: Healthy

Treatments: Dietary Supplement: Placebo; Dietary Supplement: L-arabinose and indigestible dextrin

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01039662

eki-199

Details and patient eligibility

About

This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on dietary glycemic index.

Enrollment: 19 patients

Sex: All

Ages: 20 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy as based on medical history and physical examination
• BMI is less or equal to 30 kg/m2
• Willing not to serve as blood donor during the study
• Informed consent signed

Exclusion criteria

• Impaired Glucose Tolerance
• Female subjects who are pregnant or nursing a child
• Participation in any clinical trial up to 90 days before Day 1 of this study
• Renal or hepatic dysfunction
• Heart disease
• Under medication

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

19 participants in 2 patient groups, including a placebo group

Oolong tea containing L-arabinose and indigestible dextrin

Experimental group

Treatment:

Dietary Supplement: L-arabinose and indigestible dextrin

Oolong tea

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo

Sponsors of this trial

Lead Sponsor

Hiroshima University

Collaborating Sponsor

Unitika